HI
LYRA

Harbour Investments’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Harbour Investments’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4
Closed -$2K – 3250
2021
Q3 		$2K Hold
4
– – ﹤0.01% 3325
2021
Q2 		$1K Sell
4
-22
-85% -$10K ﹤0.01% 3597
2021
Q1 		$15K Buy
+26
New +$16.2K ﹤0.01% 2370

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Harbour Investments's LYRA Position: Q4 2021 in Review

Harbour Investments sold out of LYRA THERAPEUTICS INC (LYRA) in Q4 2021, closing a stake of 4 shares — an estimated $2K sold.

Harbour Investments first reported a position in LYRA in Q1 2021 and held it in 3 quarters. The position peaked at $15K in Q1 2021. 33 funds tracked by Wall St. Rank hold LYRA as of Q4 2021.

  • Harbour Investments reported no remaining LYRA THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 4 LYRA THERAPEUTICS INC shares in Q4 2021, an estimated $2K.
  • Harbour Investments first reported a position in LYRA THERAPEUTICS INC in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's LYRA THERAPEUTICS INC position peaked at $15K in Q1 2021.
  • 33 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.